Envoy Medical, Inc. (NASDAQ:COCHW – Get Free Report) saw a large increase in short interest in October. As of October 15th, there was short interest totaling 8,851 shares, an increase of 308.3% from the September 30th total of 2,168 shares. Based on an average daily volume of 16,216 shares, the short-interest ratio is presently 0.5 days.
Envoy Medical Price Performance
NASDAQ COCHW opened at $0.03 on Friday. The company has a fifty day simple moving average of $0.04 and a 200 day simple moving average of $0.05. Envoy Medical has a 12-month low of $0.02 and a 12-month high of $0.10.
About Envoy Medical
Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with hearing loss. The company’s technologies are designed to use the body’s natural anatomy to capture sound and deliver auditory stimulation, with the goal of providing hearing restoration without the external components required by many conventional hearing devices.
Envoy Medical’s lead product is the Acclaim cochlear implant, a fully implanted device intended for adults with sensorineural hearing loss who may benefit from cochlear implantation.
Further Reading
- Five stocks we like better than Envoy Medical
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Envoy Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envoy Medical and related companies with MarketBeat.com's FREE daily email newsletter.
